264 related articles for article (PubMed ID: 2292657)
41. Utility of 8F-FDG PET/CT in well differentiated thyroid carcinoma with high serum antithyroglobulin antibody.
Kingpetch K; Pipatrattana R; Tepmongkol S; Sirisalipoch S; Chaiwatanarat T
J Med Assoc Thai; 2011 Oct; 94(10):1238-44. PubMed ID: 22145510
[TBL] [Abstract][Full Text] [Related]
42. Determination of thyroglobulin levels by radioimmunoassay method in anti thyroglobulin positive differentiated thyroid patients: One center clinical experience.
Ucar B; Sen M; Acar T; Demirkol MO
Appl Radiat Isot; 2020 Dec; 166():109400. PubMed ID: 32956923
[TBL] [Abstract][Full Text] [Related]
43. [Positive antithyroglobulin antibodies in patients with differentiated thyroid carcinoma. What significance?].
Larbre H; Schvartz C; Schneider N; Delcourt AC; Maes B; Pochart JM; Vaudrey C
Ann Endocrinol (Paris); 2000 Nov; 61(5):422-7. PubMed ID: 11084393
[TBL] [Abstract][Full Text] [Related]
44. Changes in serum thyroglobulin antibody levels as a dynamic prognostic factor for early-phase recurrence of thyroglobulin antibody-positive papillary thyroid carcinoma after total thyroidectomy.
Yamada O; Miyauchi A; Ito Y; Nakayama A; Yabuta T; Masuoka H; Fukushima M; Higashiyama T; Kihara M; Kobayashi K; Miya A
Endocr J; 2014; 61(10):961-5. PubMed ID: 25029954
[TBL] [Abstract][Full Text] [Related]
45. Influence of thyroid substitution therapy and thyroid autoantibodies on the value of serum thyroglobulin in recurring thyroid cancer.
Feldt-Rasmussen U; Holten I; Hansen HS
Cancer; 1983 Jun; 51(12):2240-4. PubMed ID: 6850505
[TBL] [Abstract][Full Text] [Related]
46. Performance Evaluation of the Serum Thyroglobulin Assays With Immunochemiluminometric Assay and Immunoradiometric Assay for Differentiated Thyroid Cancer.
Cho YY; Chun S; Lee SY; Chung JH; Park HD; Kim SW
Ann Lab Med; 2016 Sep; 36(5):413-9. PubMed ID: 27374705
[TBL] [Abstract][Full Text] [Related]
47. Anti-thyroglobulin antibodies in differentiated thyroid carcinoma patients: Study of the clinical and biological parameters.
Rahmoun MN; Bendahmane I
Ann Endocrinol (Paris); 2014 Feb; 75(1):15-8. PubMed ID: 24560398
[TBL] [Abstract][Full Text] [Related]
48. Serum thyroglobulin (Tg) and thyroglobulin antibodies (TgAb) in thyroid cancer.
Sundram FX; Sethi VK; Aw SE
Ann Acad Med Singap; 1986 Oct; 15(4):535-8. PubMed ID: 3566173
[TBL] [Abstract][Full Text] [Related]
49. Thyroglobulin autoantibodies before radioiodine ablation predict differentiated thyroid cancer outcome.
Trimboli P; Zilioli V; Imperiali M; Giovanella L
Clin Chem Lab Med; 2017 Oct; 55(12):1995-2001. PubMed ID: 28467308
[TBL] [Abstract][Full Text] [Related]
50. Predictive value of preablation stimulated thyroglobulin and thyroglobulin/thyroid-stimulating hormone ratio in differentiated thyroid cancer.
Lin Y; Li T; Liang J; Li X; Qiu L; Wang S; Chen Y; Kang Z; Li F
Clin Nucl Med; 2011 Dec; 36(12):1102-5. PubMed ID: 22064080
[TBL] [Abstract][Full Text] [Related]
51. Antithyroglobulin antibodies in patients with differentiated thyroid carcinoma: methods of detection, interference with serum thyroglobulin measurement and clinical significance.
Rosário PW; Maia FF; Fagundes TA; Vasconcelos FP; Cardoso LD; Purisch S
Arq Bras Endocrinol Metabol; 2004 Aug; 48(4):487-92. PubMed ID: 15761511
[TBL] [Abstract][Full Text] [Related]
52. Highly sensitive serum thyroglobulin and circulating thyroglobulin mRNA evaluations in the management of patients with differentiated thyroid cancer in apparent remission.
Fugazzola L; Mihalich A; Persani L; Cerutti N; Reina M; Bonomi M; Ponti E; Mannavola D; Giammona E; Vannucchi G; di Blasio AM; Beck-Peccoz P
J Clin Endocrinol Metab; 2002 Jul; 87(7):3201-8. PubMed ID: 12107225
[TBL] [Abstract][Full Text] [Related]
53. Value of the negative PET-FDG in the middle term follow-up of differentiated thyroid cancer in patients with negative 131 I-Na scan and elevated thyroglobulin serum levels.
Pachón-Garrudo VM; Cuenca-Cuenca JI; Ruiz-Franco-Baux J; Borrego-Dorado I; Tirado-Hospital JL; Navarro-González E; Vázquez-Albertino R
Rev Esp Med Nucl Imagen Mol; 2012; 31(6):315-21. PubMed ID: 23084014
[TBL] [Abstract][Full Text] [Related]
54. Sensitivity of 123I whole-body scan and thyroglobulin in the detection of metastases or recurrent differentiated thyroid cancer.
de Geus-Oei LF; Oei HY; Hennemann G; Krenning EP
Eur J Nucl Med Mol Imaging; 2002 Jun; 29(6):768-74. PubMed ID: 12029550
[TBL] [Abstract][Full Text] [Related]
55. Impact of co-existent thyroiditis on clinical outcome in papillary thyroid carcinoma with high preoperative serum antithyroglobulin antibody: a retrospective cohort study.
Nam HY; Lee HY; Park GC
Clin Otolaryngol; 2016 Aug; 41(4):358-64. PubMed ID: 26283460
[TBL] [Abstract][Full Text] [Related]
56. Discordance in thyroglobulin measurements by radioimmunoassay and immunometric assay: a useful means of identifying thyroglobulin assay interference.
Crane MS; Strachan MW; Toft AD; Beckett GJ
Ann Clin Biochem; 2013 Sep; 50(Pt 5):421-32. PubMed ID: 23847033
[TBL] [Abstract][Full Text] [Related]
57. Importance of measurement of thyroglobulin and anti-thyroglobulin antibodies in differentiated thyroid cancer.
Alagić-Smailbegović J; Kucukalić-Selimović E; Setić I; Bećirović M; Begović L
Coll Antropol; 2012 Nov; 36 Suppl 2():33-8. PubMed ID: 23397752
[TBL] [Abstract][Full Text] [Related]
58. Serum thyroglobulin levels at the time of 131I remnant ablation just after thyroidectomy are useful for early prediction of clinical recurrence in low-risk patients with differentiated thyroid carcinoma.
Kim TY; Kim WB; Kim ES; Ryu JS; Yeo JS; Kim SC; Hong SJ; Shong YK
J Clin Endocrinol Metab; 2005 Mar; 90(3):1440-5. PubMed ID: 15613412
[TBL] [Abstract][Full Text] [Related]
59. Thyroglobulin antibodies could be a potential predictive marker for papillary thyroid carcinoma.
Vasileiadis I; Boutzios G; Charitoudis G; Koukoulioti E; Karatzas T
Ann Surg Oncol; 2014 Aug; 21(8):2725-32. PubMed ID: 24595799
[TBL] [Abstract][Full Text] [Related]
60. Preoperative undetectable serum thyroglobulin in differentiated thyroid carcinoma: incidence, causes and management strategy.
Giovanella L; Ceriani L; Ghelfo A; Maffioli M; Keller F
Clin Endocrinol (Oxf); 2007 Oct; 67(4):547-51. PubMed ID: 17561976
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
